Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|---|---|
BT-549 | AZD7762 | 0.31623 | CHK1/2 | Cell cycle | -0.0478 | 0.29963 |
BT-549 | Volasertib | 0.01 | PLK | Cell cycle | 0.4084 | 0.12761 |
BT-549 | Palbociclib | 0.031623 | CDK4/6 | Cell cycle | 1.0582 | -0.00203 |
BT-549 | Palbociclib | 0.01 | CDK4/6 | Cell cycle | 1.0649 | 0.00372 |
BT-549 | Palbociclib | 0.1 | CDK4/6 | Cell cycle | 1.0491 | 0.00209 |
BT-549 | Palbociclib | 0.001 | CDK4/6 | Cell cycle | 1.0331 | 0.00886 |
BT-549 | Olaparib | 3.1623 | PARP | Misc | 0.8983 | 0.01703 |
BT-549 | Palbociclib | 0.00031623 | CDK4/6 | Cell cycle | 1.0163 | 0.00360 |
BT-549 | Palbociclib | 0.0031623 | CDK4/6 | Cell cycle | 1.0202 | -0.00027 |
BT-549 | Palbociclib | 0.31623 | CDK4/6 | Cell cycle | 1.0356 | -0.00357 |
BT-549 | Abemaciclib | 1.0 | CDK4/6 | Cell cycle | 0.8898 | 0.00509 |
BT-549 | Abemaciclib | 0.31623 | CDK4/6 | Cell cycle | 0.9772 | -0.01089 |
BT-549 | Abemaciclib | 3.1623 | CDK4/6 | Cell cycle | 0.5941 | 0.02941 |
BT-549 | Abemaciclib | 0.01 | CDK4/6 | Cell cycle | 1.0191 | 0.00387 |
BT-549 | Abemaciclib | 0.031623 | CDK4/6 | Cell cycle | 0.9941 | -0.00435 |
BT-549 | Abemaciclib | 0.1 | CDK4/6 | Cell cycle | 0.9609 | 0.00055 |
BT-549 | Abemaciclib | 10.0 | CDK4/6 | Cell cycle | 0.0333 | 0.15095 |
BT-549 | Palbociclib | 1.0 | CDK4/6 | Cell cycle | 1.0826 | -0.00648 |
BT-549 | Volasertib | 0.031623 | PLK | Cell cycle | -0.0976 | 0.27861 |
BT-549 | Taxol | 0.00031623 | Chemo | Chemotherapy | 1.0248 | 0.00400 |
BT-549 | Abemaciclib | 0.0031623 | CDK4/6 | Cell cycle | 1.0379 | -0.00284 |
BT-549 | Taxol | 0.001 | Chemo | Chemotherapy | 0.9713 | 0.02904 |
BT-549 | Ipatasertib | 0.1 | AKT | PI3K/mTOR | 0.8348 | 0.00416 |
BT-549 | Taselisib | 0.1 | PI3Ka, g, d | PI3K/mTOR | 0.8505 | 0.01194 |
BT-549 | Taselisib | 0.031623 | PI3Ka, g, d | PI3K/mTOR | 0.9123 | 0.02093 |